Thu, November 5, 2020
Wed, November 4, 2020
Tue, November 3, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $17 on, Nov 4th, 2020

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $16 to $17 on, Nov 4th, 2020.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30